Cargando…
How Can the Evidence from Global Large-scale Clinical Trials for Cardiovascular Diseases be Improved?
BACKGROUND: Clinical investigations are important for obtaining evidence to improve medical treatment. Large-scale clinical trials with thousands of participants are particularly important for this purpose in cardiovascular diseases. Conducting large-scale clinical trials entails high research costs...
Autores principales: | Sawata, Hiroshi, Tsutani, Kiichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224457/ https://www.ncbi.nlm.nih.gov/pubmed/21714928 http://dx.doi.org/10.1186/1756-0500-4-222 |
Ejemplares similares
-
Funding and infrastructure among large-scale clinical trials examining cardiovascular diseases in Japan: evidence from a questionnaire survey
por: Sawata, Hiroshi, et al.
Publicado: (2011) -
Limited accessibility to designs and results of Japanese large-scale clinical trials for cardiovascular diseases
por: Sawata, Hiroshi, et al.
Publicado: (2011) -
Compliance of Clinical Trial Protocols for Foods with Function Claims (FFC) in Japan: Consistency between Clinical Trial Registrations and Published Reports
por: Kamioka, Hiroharu, et al.
Publicado: (2021) -
Clinical trial registration, and publication in acupuncture studies: A systematic review
por: Matsuura, Yuto, et al.
Publicado: (2020) -
Review of the registration of clinical trials in UMIN-CTR from 2 June 2005 to 1 June 2010 - focus on Japan domestic, academic clinical trials
por: Tang, Wentao, et al.
Publicado: (2013)